EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endo‐Epicardial vs. Endocardial‐Only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy: The EPIC‐VT Trial Design

Raphaël P Martins, Pierre Groussin, Francis Bessière, Laure Champ-Rigot iD, Jean-Baptiste Gourraud, Sophie Lepage, Jacques Mansourati, Grégoire Massoulie iD, Philippe Maury iD, Sandro Ninni, Bertrand Pierre, Frédéric Sacher und 7 weitere

Journal of Cardiovascular Electrophysiology · 2025

DOI: 10.1111/jce.16630 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Raphaël P Martins und 18 weiteren Autor:innen. Beteiligte Einrichtung: Univ Rennes, CHU Rennes, INSERM, Rennes, France. Hauptthemen laut MEDLINE: Cardiomyopathies, Catheter Ablation, Endocardium, Myocardial Ischemia. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Radiofrequency ablation is a cornerstone therapy for patients with ischemic cardiomyopathy (ICM) presenting with ventricular tachycardia (VT). In this context, ablation is typically performed endocardially as a first‐line approach. However, despite acute procedural success, the risk of recurrence remains high, potentially due to the presence of epicardial substrate. Several observational studies have suggested the potential benefits of a first‐line endo‐epicardial approach in decreasing recurrence. In this context, the EPIC‐VT trial was designed to compare endocardial‐only ablation versus combined endo‐epicardial ablation as a first‐line approach in ICM patients with VT.

Methods

The EPIC‐VT trial is a prospective, multicenter, controlled, randomized, open‐label superiority trial with two parallel groups (endocardial‐only approach vs . combined endo‐epicardial approach) in a 1:1 ratio. The primary objective of this study is to demonstrate that a combined endo‐epicardial approach reduces the risk of VT recurrence compared to an endocardial approach alone in patients with ICM. Patients will be followed for 2 years after the procedure. Results and Conclusion To date, only retrospective studies have compared VA recurrences in patients with ICM, depending on whether ablation was performed using an endocardial or an endo‐epicardial approach, with conflicting results. A meta‐analysis suggested an advantage of the endo‐epicardial approach over the endocardial approach (odds ratio = 0.39 [95% CI: 0.18–0.83]). However, the level of evidence remains low, and no controlled randomized study has confirmed this hypothesis. If the EPIC‐VT study confirms the superiority of a first‐line endo‐epicardial approach, such strategy could become the preferred option for VT ablation in ICM, thereby reducing the risk of VA recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CardiomyopathiesCatheter AblationEndocardiumMyocardial IschemiaPericardiumTachycardia, VentricularFemaleHumansMaleAction PotentialsEquivalence Trials as TopicHeart RateMulticenter Studies as TopicProspective StudiesRecurrenceRisk FactorsTime FactorsTreatment OutcomeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Epicardialcatheter ablationventricular tachycardia

Autor:innen und Institutionen

  • Univ Rennes, CHU Rennes, INSERM, Rennes, France.
  • Department of Cardiac Surgery, "Louis Pradel" Cardiologic Hospital, Lyon, France.
  • Department of Cardiology, University Hospital of Caen, Caen, France.
  • Department of Cardiology, CHU Nantes, Nantes, France.
  • Department of Cardiology, CHU Angers, Angers, France.
  • Department of Cardiology, CHU Brest, Brest, France.

ORCID-Profile: Laure Champ-Rigot, Grégoire Massoulie, Philippe Maury

Zitieren

APA

Martins, R. P., Groussin, P., Bessière, F., Champ-Rigot, L., Gourraud, J. B., Lepage, S., Mansourati, J., Massoulie, G., Maury, P., Ninni, S., Pierre, B., Sacher, F., Varlet, E., Waintraub, X., Locher, C., Pavin, D., Mabo, P., Leclercq, C., & Benali, K. (2025). Endo‐Epicardial vs. Endocardial‐Only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy: The EPIC‐VT Trial Design. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16630

Vancouver

Martins RP, Groussin P, Bessière F, Champ-Rigot L, Gourraud JB, Lepage S, et al. Endo‐Epicardial vs. Endocardial‐Only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy: The EPIC‐VT Trial Design. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16630

BibTeX
@article{Martins2025,
  author = {Martins, Raphaël P and Groussin, Pierre and Bessière, Francis and Champ-Rigot, Laure and Gourraud, Jean-Baptiste and Lepage, Sophie and Mansourati, Jacques and Massoulie, Grégoire and Maury, Philippe and Ninni, Sandro and Pierre, Bertrand and Sacher, Frédéric and Varlet, Emilie and Waintraub, Xavier and Locher, Clara and Pavin, Dominique and Mabo, Philippe and Leclercq, Christophe and Benali, Karim},
  title = {Endo‐Epicardial vs. Endocardial‐Only Catheter Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy: The EPIC‐VT Trial Design},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  doi = {10.1111/jce.16630}
}
Kostenlos starten →